| Note: This medical device record is a PMA supplement. A supplement may have changed the device description/function or indication from that approved in the original PMA. Be sure to look at the original PMA record for more information. |
| |
| Device | BRACANALYSIS CDX |
| Generic Name | Cancer-related germline gene mutation detection system |
| Applicant | Myriad Genetic Laboratories 320 Wakara Way Salt Lake Cit, UT 84108 |
| PMA Number | P140020 |
| Supplement Number | S008 |
| Date Received | 10/27/2016 |
| Decision Date | 01/30/2017 |
| Product Code |
PJG |
| Advisory Committee |
Pathology |
| Supplement Type | Normal 180 Day Track |
| Supplement Reason | Labeling Change - Indications/instructions/shelf life/tradename |
| Expedited Review Granted? | No |
| Combination Product | No |
| Predetermined Change Control Plan Authorized | No |
Approval Order Statement Approval for the inclusion of the BRACAnalysis CDx - DNA Quantification Technical Manual, the BRACAnalysis CDx - Sanger Technical Manual, and the BRACAnalysis CDX – BART Technical Manual in place of several laboratory Standard Operating Procedures. |
|
|